AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3521856
Drug: Fluocinonide gel
RxNorm normalized name: Fluocinonide Gel
DrugBank: Fluocinonide (DB01047)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluocinonide gel 0.05%
Trial: 28241237
Drug: Testosterone gel
RxNorm normalized name: Androgel 1.62% Metered Dose Pump Testosterone Gel
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Testosterone gel (dose adjusted to maintain normal testosterone levels for young men)
Trial: 25853877
Drug: Creatine supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine supplementation (25 g/d for the first 5 days followed by 5 g/d for 8 weeks)
Trial: 24043457
Drug: Transdermal patch
RxNorm normalized name: TRANSDERMAL PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal patch containing 0.55 mg ethinyl estradiol and 2.1 mg gestodene
Trial: 24043457
Drug: Monophasic oral
RxNorm normalized name: hyoscyamine / methenamine / methylene blue / phenyl salicylate / sodium phosphate, monobasic Oral Tablet [Urelle]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Monophasic oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel
Trial: 19059933
Drug: Low-dose cidofovir
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cidofovir (0.5 mg/kg) every 2 weeks for a total of six doses
Trial: 19059933
Drug: Non-cidofovir treatment
RxNorm normalized name: Cidofovir
DrugBank: Cidofovir (DB00369)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-cidofovir treatment (control group)
Trial: 19059933
Drug: Low-dose cidofovir
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cidofovir
Trial: 9612115
Drug: EGb 761
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EGb 761 (3 times 1 film-coated tablet daily for 24 weeks)
Trial: 9612115
Drug: Placebo (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (3 times 1 film-coated tablet daily for 24 weeks)
Trial: 2734718
Drug: Theophylline (Planphylline)
RxNorm normalized name: Theophylline
DrugBank: Theophylline (DB00277)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Theophylline (Planphylline) 10 mg/kg/day in two doses at 8.30 a.m. and 8.30 p.m.
Trial: 31077596
Drug: Cat-PAD (peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cat-PAD (peptide immunotherapy)
Trial: 23218193
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (≥ 28 cDDDs)
Trial: 23218193
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (cDDDs 28 to 90)
Trial: 23218193
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (cDDDs 91 to 365)
Trial: 23218193
Drug: Statin therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin therapy (cDDDs > 365)
Trial: 19333948
Drug: Relaxin therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Relaxin therapy (both doses)
Trial: 11320044
Drug: Oral erythromycin
RxNorm normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral erythromycin (12.5 mg/kg, every six hours for 14 days)
Trial: 2959308
Drug: Oral terfenadine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral terfenadine 120 mg (pretreatment)
Trial: 2959308
Drug: Oral cimetidine
RxNorm normalized name: Cimetidine
DrugBank: Cimetidine (DB00501)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral cimetidine 400 mg (pretreatment)
Trial: 30040760
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (general physical therapy)
Trial: 26625516
Drug: Fixed combination
RxNorm normalized name: Progestogens and estrogens, fixed combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed combination of Lisinopril and Amlodipine
Trial: 18417083
Drug: Radiation Therapy
RxNorm normalized name: Sensitizers used in photodynamic/radiation therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Radiation Therapy (RT) after Breast-Conserving Surgery (BCS)
Trial: 18417083
Drug: No Radiation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Radiation Therapy (RT) after Breast-Conserving Surgery (BCS)
Trial: 12212127
Drug: Inhalation of
RxNorm normalized name: Ocean brand of sodium chloride Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhalation of 20 ppm nitric oxide (NO) during the early phase of reperfusion
Trial: 12212127
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no nitric oxide inhalation)
Trial: 9116275
Drug: Hydroxyurea (HU)
RxNorm normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyurea (HU) maintenance therapy (5 to 10 mg/kg/d) after 32P treatment
Trial: 9116275
Drug: 32P treatment
RxNorm normalized name: benzoyl peroxide
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 32P treatment alone
Trial: 9116275
Drug: Hydroxyurea (HU)
RxNorm normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyurea (HU) maintenance therapy
Trial: 9116275
Drug: Hydroxyurea (HU)
RxNorm normalized name: Hydroxyurea
DrugBank: Hydroxyurea (DB01005)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hydroxyurea (HU) maintenance therapy in severe cases with rapid recurrence
Trial: 7960627
Drug: Volumetric acquisitions
RxNorm normalized name: SETS,VOLUMETRIC,INTRAVENOUS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Volumetric acquisitions with intravenous gadolinium
Trial: 7960627
Drug: Two-dimensional interleaved
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-dimensional interleaved gradient-recalled-echo pulse sequences with intravenous gadolinium
Trial: 2884811
Drug: Dixyrazine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dixyrazine (50 mg/day)
Trial: 31715274
Drug: Rapid responders
RxNorm normalized name: Abreva Rapid Pain Relief
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rapid responders (≥80% decrease in level of AST after 8 weeks of treatment with predniso(lo)ne)
Trial: 26669201
Drug: Red-hot needle
RxNorm normalized name: Red Hot
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Red-hot needle therapy combined with cupping
Trial: 23123791
Drug: 12-week pragmatic
RxNorm normalized name: risedronate
DrugBank: Risedronic acid (DB00884)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 12-week pragmatic exercise therapy intervention
Trial: 14519140
Drug: 1 g/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g/day vitamin C
Trial: 14519140
Drug: 450 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 450 mg/day magnesium chelate
Trial: 12651048
Drug: Intravenous milrinone
RxNorm normalized name: Milrinone
DrugBank: Milrinone (DB00235)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous milrinone for 48 to 72 hours
Trial: 9053533
Drug: Vancomycin (VCM)
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vancomycin (VCM) in combination with beta-lactam antibiotics
Trial: 9053533
Drug: Vancomycin (VCM)
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vancomycin (VCM) alone or in combination with another drug
Trial: 9053533
Drug: Vancomycin (VCM)
RxNorm normalized name: Vancomycin
DrugBank: Vancomycin (DB00512)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vancomycin (VCM) in combination with other antibiotics
Trial: 2069371
Drug: Lomefloxacin (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lomefloxacin (400 mg) administered orally once daily for 5 days
Trial: 2069371
Drug: Placebo administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo administered orally once daily for 5 days
Trial: 20436517
Drug: Chemotherapy +
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy + filgrastim (r-metHuG-CSF)
Trial: 20436517
Drug: Arm B
RxNorm normalized name: arm brace
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arm B (Chemotherapy + filgrastim)
Trial: 18360781
Drug: Standard BP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard BP treatment (MAP 110-130 mmHg)
Trial: 8330599
Drug: i.m. buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. buprenorphine 0.3 mg
Trial: 8330599
Drug: i.m. buprenorphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.m. buprenorphine 0.3 mg (prophylactic)
Trial: 27060419
Drug: Short and
RxNorm normalized name: ALLERGENIC EXTRACT,RAGWEED,SHORT AND TALL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short and intensive speech therapy (6 hours over 3-4 days)
Trial: 16216530
Drug: Sex hormones
RxNorm normalized name: GENITO URINARY SYSTEM AND SEX HORMONES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sex hormones among HT users
Trial: 9170894
Drug: Zinc gluconate
RxNorm normalized name: Zinc Gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc gluconate lozenges, administered every 2 hours for the duration of cold symptoms
Trial: 9170894
Drug: Placebo lozenges,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo lozenges, administered every 2 hours for the duration of cold symptoms
Trial: 31221565
Drug: Topical nepafenac
RxNorm normalized name: Nepafenac
DrugBank: Nepafenac (DB06802)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical nepafenac 0.3%
Trial: 22117983
Drug: Wheat dextrin
RxNorm normalized name: wheat dextrin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat dextrin (15 g/day)
Trial: 9175240
Drug: Placebo (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (15 g/day)
Trial: 19213680
Drug: Dronedarone, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dronedarone, 400 mg twice a day
Trial: 16838229
Drug: Nitazoxanide (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitazoxanide (500 mg 2 times per day for 7 days)
Trial: 16838229
Drug: Nitazoxanide (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitazoxanide (500 mg 2 times per day for 10 days)
Trial: 16838229
Drug: Metronidazole (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole (250 mg 4 times per day for 10 days)
Trial: 9109584
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment with headgear
Trial: 9109584
Drug: Early treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Early treatment with modified bionator
Trial: 3813141
Drug: Oral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam premedication
Trial: 3813141
Drug: Intramuscular diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular diazepam premedication
Trial: 24965823
Drug: Rituximab (375
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rituximab (375 mg/m²) once weekly for 4 weeks
Trial: 20179981
Drug: Avocado soybean
RxNorm normalized name: Avocado
DrugBank: Avocado (DB10504)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avocado soybean unsaponifiable (Piascledine) 300 mg once daily
Trial: 20179981
Drug: Chondroitin sulfate
RxNorm normalized name: Chondroitin Sulfate
DrugBank: Chondroitin sulfate (DB09301)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chondroitin sulfate 400 mg three times daily
Trial: 9857355
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of 5, 10, 20 or 40 micrograms of a new hepatitis B vaccine
Trial: 9857355
Drug: Single dose
RxNorm normalized name: Citrucel Single Dose Packets (Orange)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single dose of 20 micrograms of the vaccine
Trial: 9857355
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of 20 micrograms or 40 micrograms of the vaccine formulation
Trial: 15100667
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy (subcutaneous injections of a mixture of Dermatophagoides pteronyssinus and Dermatophagoides farinae vaccine; n=41)
Trial: 11430712
Drug: Oral E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral E2 6-11 microg/kg/d in the evening with GH 0.1 IU/kg/d sc at bedtime
Trial: 11430712
Drug: Oral E2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral E2 6-11 microg/kg/d in the morning with GH 0.1 IU/kg/d sc at bedtime
Trial: 29406821
Drug: Goiter dispersion
RxNorm normalized name: Disperse Blue 106
DrugBank: Disperse Blue 106 (DB14203)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Goiter dispersion formula and antithyroid drugs (methimazole or propylthiouracil)
Trial: 29406821
Drug: Antithyroid drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antithyroid drug alone
Trial: 28606450
Drug: Hourly recorded
RxNorm normalized name: Recorlev
DrugBank: Levoketoconazole (DB05667)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hourly recorded messages in a family member's voice during waking hours over 3 ICU days
Trial: 28606450
Drug: Hourly recorded
RxNorm normalized name: Recorlev
DrugBank: Levoketoconazole (DB05667)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hourly recorded messages in a non-family voice during waking hours over 3 ICU days
Trial: 1794297
Drug: L-carnitine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (2 g orally daily for 6 months)
Trial: 30635256
Drug: Fronto-temporal tDCS
RxNorm normalized name: Sus scrofa temporal lobe preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fronto-temporal tDCS (2-mA, twice-daily sessions for 5 days)
Trial: 27534747
Drug: Dydrogesterone 40
RxNorm normalized name: Dydrogesterone
DrugBank: Dydrogesterone (DB00378)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Dydrogesterone 40 mg per os, followed by 10 mg per os three times a day until twelve completed weeks of gestation or 1 week after the bleeding has stopped, whichever is longer.
Trial: 19636975
Drug: Ambroxol (90
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ambroxol (90 mg, three times per day for 3 months)
Trial: 16923362
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no ambroxol treatment)
Trial: 16316362
Drug: IV iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV iron sucrose (1 g in divided IV doses over 14 days)
Trial: 16316362
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron (ferrous sulfate, 325 mg orally thrice daily for 56 days)
Trial: 16316362
Drug: IV iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV iron sucrose (200 mg IV over two to five minutes)
Trial: 9594486
Drug: Salmeterol xinafoate
RxNorm normalized name: Salmeterol Xinafoate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Salmeterol xinafoate inhaled twice daily
Trial: 31574114
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) infusion of 10 IU oxytocin
Trial: 31574114
Drug: Intramuscular (IM)
RxNorm normalized name: intramuscular immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular (IM) injection of 10 IU oxytocin
Trial: 3161703
Drug: Diflunisal once
RxNorm normalized name: Diflunisal
DrugBank: Diflunisal (DB00861)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diflunisal once daily (500 mg or 1000 mg)
Trial: 3161703
Drug: Diflunisal twice
RxNorm normalized name: Diflunisal
DrugBank: Diflunisal (DB00861)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diflunisal twice daily
Trial: 20924215
Drug: Clevudine 30
RxNorm normalized name: zinc pyrithione
DrugBank: Pyrithione (DB06815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clevudine 30 mg daily
Trial: 17650294
Drug: Hepimmune vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hepimmune vaccine (four injections in 2 weeks intervals)
Trial: 17650294
Drug: Standard HBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard HBV vaccine (HBVAXPRO)
Trial: 12182370
Drug: Alcohol-based hand
RxNorm normalized name: ALCOHOL 300 mL in 500 mL EXTRACORPOREAL GEL [JINHUI Alcohol-Based Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol-based hand gel with multifaceted quality improvement (QI) interventions
Trial: 18171181
Drug: Alcohol-based hand
RxNorm normalized name: ALCOHOL 300 mL in 500 mL EXTRACORPOREAL GEL [JINHUI Alcohol-Based Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol-based hand gel
Trial: 12182370
Drug: Alcohol-based hand
RxNorm normalized name: ALCOHOL 300 mL in 500 mL EXTRACORPOREAL GEL [JINHUI Alcohol-Based Hand Sanitizer]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alcohol-based hand gel with QI support
Trial: 9476749
Drug: Late sleep
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late sleep deprivation (LSD) twice weekly during week 1 and 2 followed by LSD once weekly during week 3 and 4
Trial: 9476749
Drug: Late sleep
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late sleep deprivation (LSD) once weekly
Trial: 9476749
Drug: Late sleep
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Late sleep deprivation (LSD) twice weekly followed by once weekly
Trial: 2146040
Drug: Patients on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Patients on diuretic therapy
Trial: 219471
Drug: Chlorthalidone (diuretic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chlorthalidone (diuretic therapy)
Trial: 31907833
Drug: Sublingual trinitroglycerin
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual trinitroglycerin (TNG)
Trial: 31907833
Drug: Intravenous adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous adenosine (AD)
Trial: 31915072
Drug: High-dose intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose intravenous vitamin C (50 mg/kg every 6 h for 96 h)
Trial: 30731195
Drug: Nucleot(s)ide analogue
RxNorm normalized name: gonadotropin releasing factor analog-diphtheria toxoid conjugate Injectable Solution [Improvest]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nucleot(s)ide analogue therapy
Trial: 26460293
Drug: Budesonide 160
RxNorm normalized name: BUDESONIDE 160/FORMOTER 4.5MCG 60D INH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Budesonide 160 μg (80 μg × 2 inhalations) twice daily via pMDI
Trial: 23324079
Drug: Sorafenib in
RxNorm normalized name: Product containing sorafenib in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sorafenib in combination with TACE
Trial: 19803786
Drug: Citicoline (1000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Citicoline (1000 mg twice a day)
Trial: 9177956
Drug: Fluoxetine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine plus total sleep deprivation (TSD)
Trial: 3304827
Drug: Multiload-250 (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiload-250 (ML)
Trial: 25096315
Drug: Cognitive behavior
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive behavior group therapy for back pain (CBT-BP), six sessions.
Trial: 25096315
Drug: Unspecific occupational
RxNorm normalized name: Caviar, unspecified
DrugBank: Caviar, unspecified (DB14241)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Unspecific occupational therapy sessions (control group).
Trial: 20814330
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER (6 mg/d, flexible dosing 3-12 mg/d)
Trial: 15953743
Drug: Isotonic MgSO4
RxNorm normalized name: MgSO4
DrugBank: Magnesium sulfate (DB00653)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Isotonic MgSO4 (2.5 ml, 6.3%) + salbutamol (2.5 ml)
Trial: 15953743
Drug: Saline (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (2.5 ml) + salbutamol (2.5 ml)
Trial: 11807630
Drug: Menatetrenone (45
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menatetrenone (45 mg oral administration)
Trial: 19010347
Drug: Both groups
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both groups measured for glucose, insulin, hsCRP, IL-6, sIL-6R, TNF-alpha, sTNFR1 and sTNFRII.
Trial: 16206668
Drug: Psychotherapy and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychotherapy and Fluoxetine (20mg once a day for 12 weeks)
Trial: 16206668
Drug: Regular cardiac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular cardiac medicine therapy
Trial: 8057649
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy with vindesine (3 mg/m2 weekly x 5, then every 2 weeks x 8) and cisplatin (120 mg/m2 on days 1, 29, 71, 113) plus thoracic irradiation
Trial: 8057649
Drug: Postoperative chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Postoperative chemotherapy with vindesine and cisplatin plus thoracic irradiation
Trial: 2522134
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg of amlodipine
Trial: 2522134
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg of amlodipine
Trial: 30891721
Drug: moodgym +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: moodgym + treatment as usual (TAU)
Trial: 28708316
Drug: Plant sterols
RxNorm normalized name: Plant Sterols/Stanol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant sterols supplementation (2.0 g free plant sterols equivalent of palmityl esters daily for 4 weeks)